News
Partnership for Safe Medicines urges FDA advisory committee to reject compounding of unapproved peptides
On July 23-24, the FDA will evaluate seven peptides for custom pharmacy compounding. Citing a critical deficit in human safety data, widespread consumer confusion, and systemic supply chain vulnerabilities, PSM urges the committee to block mass compounding and protect patient safety.
[...]July 6, 2026: Judge blocks Colorado price cap on Enbrel
The nations first upper payment limit, set to take effect in January 2027, has been temporarily paused. Chief Judge Daniel Domenico said Amgen would face significant and irreparable harm because of the price cap, and found that federal patent law likely preempted a state price cap, reported Reuters.
[...]June 29, 2026: PSM releases road map to improve patient safety amidst compounding boom
A Call to Action: Restoring and Strengthening America’s Patient Safety System presents a two pillar system for regulators and lawmakers to preserve the FDAs gold standard.
[...]Joint statement on warning to pharmacists about diverted HIV medicines being sold on online pharmacy-to-pharmacy platforms
ADAP Advocacy and the Partnership for Safe Medicines (PSM) issued the following joint statement as a warning to pharmacists that all discounted HIV products bought from online, pharmacy-to-pharmacy (P2P) marketplaces fit the definition of suspect product under U.S. Food and Drug Administration (FDA) guidelines and the Drug Supply Chain Security Act.
[...]Pharmacists beware: Diverted HIV medicines are being sold on online pharmacy-to-pharmacy platforms
The Partnership for Safe Medicines and ADAP Advocacy are warning that discounted HIV products bought from online, pharmacy-to-pharmacy (P2P) marketplaces qualify as suspicious products under U.S. Food and Drug Administration guidelines and the Drug Supply Chain Security Act. Given the risks, we believe that it isn’t safe or cost-effective to purchase HIV products from these platforms.
[...]Weight loss promotions are out of hand on social media, and it’s endangering patients
The internet is overrun with content promoting injectable weight loss medicines and there’s no way for viewers to know whether what they’re seeing is legitimate, genuine, safe, or true. Policymakers, social media platforms, and individuals can make changes to protect the public in this dangerous advertising environment.
[...]Partnership for Safe Medicines releases action plan to protect patients from unapproved compounded GLP-1s
PMS’s new report outlines solutions to protect patient safety in the growing compounded GLP-1 marketplace. A Call to Action: Restoring and Strengthening America’s Patient Safety System serves as a roadmap for policymakers and regulators to uphold the gold standard system that protects Americans from untested and unsafe medicines.
[...]June 22, 2026: Study links alternative funding programs to treatment delays
AFPs, which often force patients to source medicines overseas, may present access concerns according to a new study.
[...]June 15, 2026: Colorado becomes the second state given federal approval for Canadian drug importation program
Similar importation programs have been plagued with logistical hurdles, despite extensive funding of the efforts.
[...]Partnership for Safe Medicines statement on FDA authorization of Colorado’s Section 804 Importation Program
“Colorado is now poised to repeat Florida’s failed attempt to implement Canadian drug importation,” said PSM Executive Director Shabbir Imber Safdar. “Since beginning their program in 2019, Florida has spent $132 million and still not imported a single unit of medicine, proving that these bulk importation programs are not reducing drug costs for Americans.”
[...]